Tandem Diabetes Care, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Tandem Diabetes Care, Inc. (TNDM) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $10.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-06
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $8.37M.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $1.85M, a 1.81% increase year-over-year.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $26.17M, a 2887.33% increase year-over-year.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $26.17M, a 498.83% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $4.37M.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $114.00M, a 650.46% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.22M 10-Q · filed 2026-08-06 | $10.22M derived: sum of 3 quarters · filed 2026-08-06 | $36.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.85M 10-Q · filed 2026-05-07 | $1.85M derived: sum of 2 quarters · filed 2026-05-07 | $28.02M derived: sum of 3 quarters · filed 2026-05-07 | $26.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $26.17M derived: sum of 2 quarters · filed 2026-02-19 | $24.35M derived: sum of 3 quarters · filed 2026-08-06 | $26.17M 10-K · filed 2026-02-19 |
| 2025-09-30 | $26.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $24.35M derived: sum of 2 quarters · filed 2026-08-06 | $26.17M 10-Q · filed 2025-11-06 | $25.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$289.00K derived: sum of 3 quarters · filed 2026-08-06 | $587.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.82M 10-Q · filed 2026-05-07 | $1.53M derived: sum of 2 quarters · filed 2026-05-07 | $2.41M derived: sum of 3 quarters · filed 2026-05-07 | $3.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $587.00K derived: sum of 2 quarters · filed 2026-02-19 | $2.08M derived: sum of 3 quarters · filed 2026-02-19 | $4.37M 10-K · filed 2026-02-19 |
| 2024-09-30 | $876.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.37M derived: sum of 2 quarters · filed 2025-11-06 | $4.66M 10-Q · filed 2025-11-06 | $4.66M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.78M 10-Q · filed 2025-08-06 | $3.78M derived: sum of 3 quarters · filed 2026-02-19 | $3.78M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $2.29M 10-Q · filed 2025-04-30 | $2.29M derived: sum of 2 quarters · filed 2026-02-19 | $2.29M derived: sum of 3 quarters · filed 2026-02-19 | $2.29M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $3.02M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $3.02M derived: sum of 3 quarters · filed 2025-02-26 | $3.49M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $3.02M derived: sum of 2 quarters · filed 2025-02-26 | $3.49M derived: sum of 3 quarters · filed 2025-02-26 | $6.53M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.49M derived: sum of 2 quarters · filed 2025-02-26 | $6.53M derived: sum of 3 quarters · filed 2025-02-26 | $114.00M 10-K · filed 2025-02-26 |
| 2022-09-30 | $465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $3.50M derived: sum of 2 quarters · filed 2023-11-01 | $110.98M 10-Q · filed 2023-11-01 | $111.08M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $110.52M 10-Q · filed 2023-08-03 | $110.62M derived: sum of 3 quarters · filed 2024-02-21 | $110.62M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $107.48M 10-Q · filed 2023-05-03 | $107.58M derived: sum of 2 quarters · filed 2024-02-21 | $107.58M derived: sum of 3 quarters · filed 2024-02-21 | $107.58M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $104.00K derived: sum of 2 quarters · filed 2024-02-21 | $104.00K derived: sum of 3 quarters · filed 2024-02-21 | $15.19M 10-K · filed 2024-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $15.09M 10-Q · filed 2022-11-02 | $15.09M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $15.09M 10-Q · filed 2022-08-03 | $15.09M derived: sum of 3 quarters · filed 2023-02-22 | $17.30M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $15.09M 10-Q · filed 2022-05-04 | $15.09M derived: sum of 2 quarters · filed 2023-02-22 | $17.30M derived: sum of 3 quarters · filed 2023-02-22 | $17.30M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.22M derived: sum of 2 quarters · filed 2023-02-22 | $2.22M derived: sum of 3 quarters · filed 2023-02-22 | $11.02M 10-K · filed 2023-02-22 |
| 2020-09-30 | $2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.22M derived: sum of 2 quarters · filed 2021-11-03 | $11.02M 10-Q · filed 2021-11-03 | $11.21M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $8.80M 10-Q · filed 2021-08-04 | $8.99M derived: sum of 3 quarters · filed 2022-02-22 | $8.99M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $8.80M 10-Q · filed 2021-05-05 | $8.99M derived: sum of 2 quarters · filed 2022-02-22 | $8.99M derived: sum of 3 quarters · filed 2022-02-22 | $17.39M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $190.00K derived: sum of 2 quarters · filed 2022-02-22 | $8.58M derived: sum of 3 quarters · filed 2022-02-22 | $11.63M 10-K · filed 2022-02-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.39M derived: sum of 2 quarters · filed 2020-11-05 | $11.45M 10-Q · filed 2020-11-05 | $11.45M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $8.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $11.45M 10-Q · filed 2020-07-30 | $11.45M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2019-03-31 | $3.05M 10-Q · filed 2020-04-30 | $3.05M derived: sum of 2 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 10-K · filed 2021-02-24 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |